LanzaTech Global Inc Dossier
Qualitative Analysis
Business overview
LanzaTech Global develops and licenses gas-fermentation technology that converts waste carbon into fuels, chemicals and materials. Customers generally build, own and operate the biorefineries, while LanzaTech earns engineering fees, licensing payments and royalties. Additional revenue comes from contract research and CarbonSmart product sales. The company is also pursuing selective ownership and operating roles alongside infrastructure partners. Its technology was deployed at six commercial-scale facilities as of early 2026, with cumulative production exceeding 60.0 million gallons of low-carbon ethanol. Industrial, chemical, consumer-brand and aviation relationships support deployment and downstream demand, although customer concentration and long project cycles can make revenue uneven. The platform is protected by more than 1,250 granted patents and over 575 pending applications spanning microbes, bioreactors, gas conditioning and product recovery. Sources: 0001628280-26-056933#Business
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
A comprehensive organizational restructuring and cost optimization program implemented to transition the company from an R&D innovation hub to a deployment-focused profitable enterprise.
Expected impact: Reduced SG&A and R&D expenses by more than 50% exiting 2025, lowering quarterly operating expenses to $13.5 million in Q1 2026 and targeting under $45 million for the full year 2026.
Expanding the biorefining platform to produce microbial protein directly from CO2 for animal feed, pet food, and human nutrition.
Expected impact: Diversification of revenue streams by entering the alternative protein market with a cost-competitive, land-and-water-efficient solution.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Partnering to spin out LanzaTech's synthetic biology and strain engineering platform into a dedicated business unit called LanzaX. This allows LanzaX to access independent capital while letting LanzaTech focus on its core biorefining and SAF operations.
Terms: Expected to save LanzaTech approximately $8 million in annual operating expenses.
Collaborating on the CirculAir joint offering to convert waste carbon and renewable power into Sustainable Aviation Fuel (SAF). LanzaTech participated in LanzaJet's Series A Preferred Stock round in February 2026, adjusting its common stock ownership to approximately 46%.
Terms: $2.0 million purchase of LanzaJet Series A Preferred Stock by LanzaTech.